The safety and efficacy of indinavir and ritonavir (400/400 mg BID) in HIV-1-infected individuals from an inner-city minority population: a pilot study
JAYAWEERA, D. T, SCERPELLA, E, ROBINSON, M, RODE, R, CAMPO, R, RODRIGUEZ, A, ASTHANA, D, TANNER, T, KOLBER, M. A
Published in International journal of STD & AIDS (01.11.2003)
Published in International journal of STD & AIDS (01.11.2003)
Get full text
Journal Article
OAO5-04. Gp96-Ig-SIV vaccines induce predominant immune responses at mucosal sites
Strbo, N, Vaccari, M, Pahwa, S, Kolber, MA, Fisher, E, Gonzalez, L, Felber, B K, Pavlakis, G N, Franchini, G, Podack, E R
Published in Retrovirology (22.10.2009)
Published in Retrovirology (22.10.2009)
Get full text
Journal Article
Effectiveness and tolerability of a once‐daily amprenavir/ritonavir‐containing highly active antiretroviral therapy regimen in antiretroviral‐naïve patients at risk for nonadherence: 48‐week results after 24 weeks of directly observed therapy
Jayaweera, DT, Kolber, MA, Brill, M, Tanner, T, Campo, R, Rodriguez, A, Chu, H‐M, Garg, V
Published in HIV medicine (01.09.2004)
Published in HIV medicine (01.09.2004)
Get full text
Journal Article
Hydrolysis of inositol phospholipids induced by stimulation of the T cell antigen receptor complex in antigen-specific, murine helper T cell clones. Requirement for exogenous calcium
Bonvini, E, DeBell, KE, Kolber, MA, Hoffman, T, Hodes, RJ, Taplits, MS
Published in The Journal of immunology (1950) (15.07.1989)
Published in The Journal of immunology (1950) (15.07.1989)
Get full text
Journal Article
The generation of cytotoxic T lymphocytes against acetaldehyde-modified syngeneic cells
Terabayashi, H, Kolber, M A
Published in Alcoholism, clinical and experimental research (01.12.1990)
Get more information
Published in Alcoholism, clinical and experimental research (01.12.1990)
Journal Article